18 insiders reported 135 Form 4 transactions for NovoCure Ltd (NVCR) over the past 18 months (most recent 2026-06-05). Recent activity: HILLEMAN JERYL L (Director) Buy 11,610 shares, LEUNG GABRIEL (Director) Buy 11,610 shares, Hung David (Director) Buy 11,610 shares, VERNON W ANTHONY (Director) Buy 11,610 shares, Scannell Timothy J (Director) Buy 11,610 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | HILLEMAN JERYL L | Director | Buy | 11,610 | $0 |
| 2026-06-05 | LEUNG GABRIEL | Director | Buy | 11,610 | $0 |
| 2026-06-05 | Hung David | Director | Buy | 11,610 | $0 |
| 2026-06-05 | VERNON W ANTHONY | Director | Buy | 11,610 | $0 |
| 2026-06-05 | Scannell Timothy J | Director | Buy | 11,610 | $0 |
| 2026-06-05 | Madden Martin J. | Director | Buy | 11,610 | $0 |
| 2026-06-05 | Leonard Frank X | Chief Executive Officer | Sell | 34,273 | $614,635 |
| 2026-06-05 | Ocean Allyson J | Director | Buy | 11,610 | $0 |
| 2026-06-05 | Stafford Kristin | Director | Buy | 11,610 | $0 |
| 2026-06-03 | Scannell Timothy J | Director | Sell | 2,945 | $46,445 |
| 2026-06-03 | LEUNG GABRIEL | Director | Sell | 2,945 | $46,445 |
| 2026-06-03 | Hung David | Director | Sell | 2,945 | $46,445 |
| 2026-06-03 | HILLEMAN JERYL L | Director | Sell | 2,945 | $46,445 |
| 2026-06-03 | Ocean Allyson J | Director | Sell | 2,945 | $46,445 |
| 2026-06-03 | Stafford Kristin | Director | Sell | 2,945 | $46,445 |
| 2026-06-03 | VERNON W ANTHONY | Director | Sell | 2,945 | $46,445 |
| 2026-04-28 | VERNON W ANTHONY | Director | Buy | 21,500 | $244,885 |
| 2026-03-05 | Brackmann Christoph | Chief Financial Officer | Buy | 55,137 | $0 |
| 2026-03-05 | DOYLE WILLIAM F | Executive Chairman | Buy | 200,000 | $0 |
| 2026-03-05 | DOYLE WILLIAM F | Executive Chairman | Buy | 200,284 | $0 |
| 2026-03-05 | DOYLE WILLIAM F | Executive Chairman | Sell | 21,330 | $286,462 |
| 2026-03-05 | Weinberg Uri | Chf Medical and Innovation Ofr | Buy | 50,125 | $0 |
| 2026-03-05 | Weinberg Uri | Chf Medical and Innovation Ofr | Sell | 6,412 | $85,344 |
| 2026-03-05 | Cordova Ashley | Former Chief Executive Officer | Sell | 17,638 | $234,585 |
| 2026-03-05 | DOYLE WILLIAM F | Executive Chairman | Sell | 50,557 | $646,624 |
Source: SEC Form 4 filings · as of 2026-06-05